Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T15:31:45.247Z.
Calculation as of: 2026-10-06T15:31:45.247Z.
Quote observation: 2026-10-06T15:30:30.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6dae1ed753b385efcb651dd8f32a10b6f9886011747f410ddce9f57bee9a14c9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Dianthus Therapeutics, Inc.
Market Cap
$4.91B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.91B
EV/EBITDA Ratio
N/A
TTM Avg
2239.52x
3Y Avg
2239.52x
5Y Avg
2239.52x
Market Cap
$4.75B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.68B
EV/EBITDA Ratio
34.99x
TTM Avg
39.32x
3Y Avg
75.54x
5Y Avg
104.36x
Market Cap
$5.08B
EV/EBITDA Ratio
16.16x
TTM Avg
15.97x
3Y Avg
19.93x
5Y Avg
21.74x
Market Cap
$4.65B
EV/EBITDA Ratio
13.97x
TTM Avg
13.23x
3Y Avg
15.13x
5Y Avg
17.95x
Market Cap
$4.62B
EV/EBITDA Ratio
75.84x
TTM Avg
416.98x
3Y Avg
416.98x
5Y Avg
416.98x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | $4.91B | N/A | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.89B | N/A | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.91B | N/A | 2239.52x | 2239.52x | 2239.52x |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.75B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 34.99x | 39.32x | 75.54x | 104.36x |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.08B | 16.16x | 15.97x | 19.93x | 21.74x |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 13.97x | 13.23x | 15.13x | 17.95x |
| Erasca, Inc. (ERAS)vs › | $5.15B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | 75.84x | 416.98x | 416.98x | 416.98x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.23B | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
